Prevalence and determinants of antiseizure medication dispensing among pregnant persons in the United States: A retrospective claims‐based cohort study, 2004–2021
British Journal of Clinical Pharmacology · 20.11.2026
DOI: 10.1002/bcp.70938 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 20.11.2026. Verfasst von Lisiane Freitas Leal und 3 weiteren Autor:innen. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canada Foundation for Innovation.
Abstract (Originalsprache)
Aim
To describe trends and identify factors associated with antiseizure medications (ASMs) dispensing among pregnant persons in the United States.
Methods
We conducted a retrospective claims‐based cohort study within AMerican PREGNANcy Mother–Child CohorT (AM‐PREGNANT). We identified pregnant persons aged 15–45 years continuously enrolled from 12 months before the last menstrual period (LMP) through pregnancy end, with ≥1 ASM dispensing from 2004 to 2021. Annual prevalence of ASM dispensing was estimated by pregnancy start year. Within a first‐ever ASM dispensing cohort, we examined dispensing patterns across pregnancy time windows, ASM‐related indications and changes in dispensing during pregnancy. We also assessed factors associated with ASM dispensing at LMP among those initiating ASM therapy before pregnancy.
Results
The cohort included 337 449 pregnant persons. Annual ASM dispensing prevalence remained stable (10%–13%). Among those with first‐ever ASM dispensing ( n = 115 896), 56% had dispensing before pregnancy, of whom 65% had no dispensing during pregnancy. The most common starting ASMs were clonazepam (28%), topiramate (25%) and gabapentin (20%). Dispensing patterns varied by indication: epilepsy was characterized by lamotrigine, levetiracetam and topiramate, generally dispensed for >60 days, whereas psychiatric and pain indications showed more variable patterns, typically with
Förderung
- Canada Foundation for Innovation
Zitieren
APA
Leal, L. F., Djidjou, P. K., Pana, R., & Bérard, A. (2026). Prevalence and determinants of antiseizure medication dispensing among pregnant persons in the United States: A retrospective claims‐based cohort study, 2004–2021. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70938
Vancouver
Leal LF, Djidjou PK, Pana R, Bérard A. Prevalence and determinants of antiseizure medication dispensing among pregnant persons in the United States: A retrospective claims‐based cohort study, 2004–2021. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70938
BibTeX
@article{Leal2026,
author = {Leal, Lisiane Freitas and Djidjou, Patricia Kammegne and Pana, Raluca and Bérard, Anick},
title = {Prevalence and determinants of antiseizure medication dispensing among pregnant persons in the United States: A retrospective claims‐based cohort study, 2004–2021},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70938}
}
EUVIMED